FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385226770> ?p ?o ?g. }

• W4385226770 endingPage "1586" @default.
• W4385226770 startingPage "1575" @default.
• W4385226770 abstract "There is limited literature regarding real-world treatment patterns of patients with COPD, particularly since the introduction of once-daily single-inhaler triple therapy with fluticasone furoate/umeclidinium/vilanterol in 2017. Here, we evaluated treatment patterns of patients with COPD before and after a COPD exacerbation.Retrospective, descriptive study using medical and pharmacy claims data and enrollment information from the Optum® Clinformatics® Data Mart database. Patients aged ≥40 years with ≥1 COPD exacerbation on or after September 18, 2017 were included. The index date was the last day of the first COPD exacerbation (ie day of visit for a moderate exacerbation or discharge date for a severe exacerbation). The baseline period was 12 months prior to index and the follow-up period (≥3 months) spanned from index until the earliest of health plan disenrollment, end of data availability (September 30, 2020), or death. Treatment patterns were evaluated during baseline and follow-up, with a focus on medication switching in the 90 days pre- and post-index.COPD exacerbations were identified in 307,727 patients (125,942 severe; 181,785 moderate). Mean age at index was 72.8 years; 56.3% were female. Before and after first exacerbation, 37.7% and 48.2% of patients used ≥1 controller medication, respectively. In the 90 days pre-index, ICS, LABA, and LAMA medications were used by 27.5% of patients. Of these users, 64.3% remained on the same medication class, 21.7% discontinued, and 14.1% switched medication in the 90 days post-index. Among switchers, 44.0% switched to triple therapy. Most common switches were ICS/LABA to ICS/LABA/LAMA (20.7%) and LAMA to ICS/LABA/LAMA (16.4%).Many COPD exacerbations occur among patients not on controller medications. Although the percentage of patients receiving a controller medication increased following a first exacerbation, it remained below 50%. Of patients receiving controller medications pre-exacerbation, only a small proportion escalated to triple therapy post-exacerbation." @default.
• W4385226770 created "2023-07-25" @default.
• W4385226770 creator A5003899519 @default.
• W4385226770 creator A5017834828 @default.
• W4385226770 creator A5061998147 @default.
• W4385226770 creator A5063896009 @default.
• W4385226770 creator A5064917859 @default.
• W4385226770 date "2023-07-01" @default.
• W4385226770 modified "2023-09-26" @default.
• W4385226770 title "Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States" @default.
• W4385226770 cites W2008074564 @default.
• W4385226770 cites W2604577460 @default.
• W4385226770 cites W2785999277 @default.
• W4385226770 cites W2802221596 @default.
• W4385226770 cites W2884384931 @default.
• W4385226770 cites W2898568303 @default.
• W4385226770 cites W2912675200 @default.
• W4385226770 cites W3008489692 @default.
• W4385226770 cites W3037411127 @default.
• W4385226770 cites W3041064922 @default.
• W4385226770 cites W3133629361 @default.
• W4385226770 cites W3153227158 @default.
• W4385226770 cites W3159166086 @default.
• W4385226770 cites W4225889303 @default.
• W4385226770 doi "https://doi.org/10.2147/copd.s398816" @default.
• W4385226770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37521022" @default.
• W4385226770 hasPublicationYear "2023" @default.
• W4385226770 type Work @default.
• W4385226770 citedByCount "0" @default.
• W4385226770 crossrefType "journal-article" @default.
• W4385226770 hasAuthorship W4385226770A5003899519 @default.
• W4385226770 hasAuthorship W4385226770A5017834828 @default.
• W4385226770 hasAuthorship W4385226770A5061998147 @default.
• W4385226770 hasAuthorship W4385226770A5063896009 @default.
• W4385226770 hasAuthorship W4385226770A5064917859 @default.
• W4385226770 hasBestOaLocation W43852267701 @default.
• W4385226770 hasConcept C104863432 @default.
• W4385226770 hasConcept C126322002 @default.
• W4385226770 hasConcept C167135981 @default.
• W4385226770 hasConcept C187212893 @default.
• W4385226770 hasConcept C194828623 @default.
• W4385226770 hasConcept C2776780178 @default.
• W4385226770 hasConcept C2776804153 @default.
• W4385226770 hasConcept C2777014857 @default.
• W4385226770 hasConcept C2779028295 @default.
• W4385226770 hasConcept C2780861865 @default.
• W4385226770 hasConcept C2910217193 @default.
• W4385226770 hasConcept C512399662 @default.
• W4385226770 hasConcept C71924100 @default.
• W4385226770 hasConceptScore W4385226770C104863432 @default.
• W4385226770 hasConceptScore W4385226770C126322002 @default.
• W4385226770 hasConceptScore W4385226770C167135981 @default.
• W4385226770 hasConceptScore W4385226770C187212893 @default.
• W4385226770 hasConceptScore W4385226770C194828623 @default.
• W4385226770 hasConceptScore W4385226770C2776780178 @default.
• W4385226770 hasConceptScore W4385226770C2776804153 @default.
• W4385226770 hasConceptScore W4385226770C2777014857 @default.
• W4385226770 hasConceptScore W4385226770C2779028295 @default.
• W4385226770 hasConceptScore W4385226770C2780861865 @default.
• W4385226770 hasConceptScore W4385226770C2910217193 @default.
• W4385226770 hasConceptScore W4385226770C512399662 @default.
• W4385226770 hasConceptScore W4385226770C71924100 @default.
• W4385226770 hasLocation W43852267701 @default.
• W4385226770 hasLocation W43852267702 @default.
• W4385226770 hasLocation W43852267703 @default.
• W4385226770 hasOpenAccess W4385226770 @default.
• W4385226770 hasPrimaryLocation W43852267701 @default.
• W4385226770 hasRelatedWork W1534309100 @default.
• W4385226770 hasRelatedWork W2009268228 @default.
• W4385226770 hasRelatedWork W2089539955 @default.
• W4385226770 hasRelatedWork W2118269576 @default.
• W4385226770 hasRelatedWork W2592115431 @default.
• W4385226770 hasRelatedWork W2970769690 @default.
• W4385226770 hasRelatedWork W2990066090 @default.
• W4385226770 hasRelatedWork W3011310803 @default.
• W4385226770 hasRelatedWork W4220762825 @default.
• W4385226770 hasRelatedWork W4237479062 @default.
• W4385226770 hasVolume "Volume 18" @default.
• W4385226770 isParatext "false" @default.
• W4385226770 isRetracted "false" @default.
• W4385226770 workType "article" @default.